Inventor

Timothy F. Herpin

Inventor
Princeton, NJ, US

Overview

15→
Patents
2003–2011
Patent span
Chemistry
Primary field (CPC C)

Patents· 15 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes13%
C07KPeptides6%
Y02ATechnologies for adaptation to climate change6%
C07CAcyclic or carbocyclic compounds4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C07BGeneral methods of organic chemistry2%
C40BCombinatorial chemistry2%
PatentTitleYear
8,053,450'Amino-benzazoles as P2Y1 receptor inhibitors with pyridine ring and heterocyclic components'20117,951,793'Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method'20117,674,828'Urea antagonists of P2Y1receptor useful in the treatment of thrombotic conditions'20107,507,757'Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method'20097,470,712'Amino-benzazoles as P2Y1 receptor inhibitors'20087,388,021'Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions'20087,279,485'Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method'20077,138,526'Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives'20067,067,525'Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same'20067,041,692'Methods of treating factor VIIa-associated conditions with compounds having an amine nucleus'20066,979,691'Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same'20056,875,782'Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method'20056,846,838'Ureido-substituted aniline compounds useful as serine protease inhibitors'20056,713,487'Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same'20046,596,747'Compounds derived from an amine nucleus and pharmaceutical compositions comprising same'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2011Patents assigned to BRISTOL MYERS SQUIBB CO (14)· patent assignee history
2003–2011Based in Princeton, NJ, US· patent location history
2006Patents assigned to AVENTIS PHARMA INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BRISTOL MYERS SQUIBB CO142003–2011
AVENTIS PHARMA INC12006
Locations
LocationPatentsSpan
Princeton, New Jersey, US152003–2011